Explore the Agenda
7:30 am Check-In, Coffee & Light Breakfast
8:25 am Chair’s Opening Remarks
Contractor Safety & Construction Excellence – Managing Risk in Capital Projects & Facility Expansions
8:30 am Building Safer Biopharma Facilities by Embedding EHS into Design from Early Planning Through Operational Handover
- Explore how to embed EHS by Design into greenfield and brownfield capital projects to identify and mitigate operational risks before construction begins
- Examine how to integrate EHS requirements into engineering and facility design decisions, ensuring safety controls are incorporated from the outset rather than addressed through costly downstream modifications
- Discuss how to align EHS, engineering and manufacturing teams across facility expansions and capital projects to support safe operational transitions and increasing production capacity
9:00 am Embedding Contractor Safety into Project Management to Prevent Incidents Without Delaying Construction
- Explore how to strengthen contractor prequalification and onboarding by assessing safety performance, verifying training and ensuring contractors understand company specific requirements before projects begin
- Discover how to simplify complex contractor safety standards and integrate them into existing project management processes to improve understanding, accountability and buy-in
- Understand how to build safety into project design and planning from the outset, maintaining consistent expectations across multiple construction projects without increasing costs or delaying timelines
9:30 am Managing Construction in Occupied Biopharma Facilities Without Compromising Safety or Operations
- Explore the unique EHS challenges of managing construction and facility modifications within occupied R&D buildings while maintaining safe, uninterrupted operations
- Examine how to coordinate EHS, facilities, construction teams and building occupants to manage competing priorities, simultaneous activities and operational risks
- Discover practical strategies for managing post-occupancy construction, including communicating changes, maintaining safety controls and minimising disruption to ongoing laboratory activities
10:00 am Speed Networking
A prime chance to make the most of in-person networking and forge new connections as new companies enter, and existing ones broaden their presence within the EHS for Biopharma Space. Designed to maximize your introduction to numerous new individuals and serve as a catalyst for ongoing discussions during the summit.
10:30 am Morning Break & Refreshments
Applying Process Safety Best Practices & Strengthening Risk Management to Prevent High- Consequence Manufacturing Incidents
11:00 am Fireside Chat: Strengthening Process Safety Strategies to Close Capability Gaps, Prioritise Critical Risks & Prevent Serious Incidents
- Discuss the challenge of finding and retaining process safety expertise, including whether to build in-house capability or rely on external consultants
- Explore how to move beyond traditional injury and incident metrics to identify significant potential events and prioritise the highest-consequence risks
- Share approaches to allocating resources towards the hazards with the greatest potential for serious harm, rather than focusing solely on incident frequency
11:30 am Roundtable Discussion: Putting Process Safety into Practice to Identify, Control & Prevent High-Risk Manufacturing Hazards
- Share practical approaches to identifying and managing process safety hazards across small molecules, APIs, ADCs and other biopharma operations, including combustible dusts, flammable materials and static electricity
- Discuss how to apply process safety principles and best practices across different facilities, including those not formally covered by OSHA PSM regulations
- Exchange lessons learned from implementing risk assessments, management of change procedures and preventative controls to strengthen process safety in day-today operations
12:00 pm Session Reserved for Aclid
12:15 pm Lunch & Networking
Environmental Compliance & Sustainability – PFAS, Waste Reduction & Strategic Environmental Management
1:15 pm Reducing Waste Management Costs & Regulatory Burden Through Smarter Waste Classification, Recycling & Operational Controls
- Explore how MannKind has reviewed and reclassified hazardous, RCRA-regulated, medical and proprietary waste streams to reduce unnecessary regulatory requirements and associated disposal cost
- Discover how targeted employee training, administrative controls, waste pretreatment, recycling and material substitution have helped reduce regulated waste volumes and improve waste management efficiency
- Learn how to identify cost-saving opportunities across existing waste streams, quantify improvements in waste management performance and incorporate these initiatives into environmental and sustainability reporting
1:45 pm Driving Measurable Waste & Water Reductions Through My Green Lab Certification & Site-Specific Sustainability Roadmaps
- Explore the use of My Green Lab certification to embed sustainable laboratory practices across AbbVie R&D sites
- Discover practical approaches to developing site-specific waste and water reduction roadmaps, identifying opportunities to reduce consumption while improving laboratory efficiency
- Share strategies for engaging laboratory teams, prioritising sustainability initiatives and measuring progress to translate environmental commitments into achievable improvements across R&D operations
2:15 pm Roundtable Discussion: What’s Working in Biopharma Waste Reduction & How Are You Measuring Its Impact?
- Share practical waste and water reduction initiatives being implemented across biopharma laboratories, identifying which approaches are delivering the greatest improvements and where challenges remain
- Compare how organisations measure the success of waste reduction efforts, from tracking waste volumes and recycling rates to quantifying disposal cost savings and reductions in resource consumption
- Discuss how to overcome barriers to employee engagement, demonstrate measurable progress and identify new opportunities for reducing waste without compromising laboratory operations
2:45 pm Afternoon Break & AI Exchange Networking
Harnessing AI to Predict Risk, Prevent Incidents & Strengthen EHS Compliance
Hear directly from EHS leaders who have put AI into practice, sharing candid case studies of what worked, what didn’t, and what they learned along the way in a series of short presentations.
- AI Show & Tell Explore short demonstrations from EHS leaders sharing the platforms, prompts and practical integrations they’ve put into practice, including what worked and what didn’t.
- Open AI Exchange Move between showcase stations to ask questions, compare experiences and discuss how different AI applications could be adapted to your own EHS operations.
- Share Your Own Experiences Bring your most useful AI prompts, successful applications or implementation challenges to the conversation and learn from the wider EHS community.
3:30 pm Sharing Best Practices for Biopharma Facility Decommissioning, Decontamination & Lease Handover
- Compare approaches to managing laboratory decontamination, clearance testing and radiation safety requirements when closing or transitioning biopharma facilities
- Discuss common challenges in coordinating decommissioning timelines, managing unexpected delays and meeting landlord lease requirements while avoiding unnecessary costs
- Share experiences of working with specialist decommissioning vendors, including when to bring in external expertise and how to ensure facilities are safely cleared and ready for handover
3:45 pm Strengthening Pharma–CDMO Collaboration to Navigate Environmental Regulations & Achieve Shared Sustainability Goals
- Address environmental compliance challenges when pharma sponsors dictate materials and manufacturing processes, while CDMOs must manage the resulting site-level risks and regulatory obligations
- Strengthen sponsor–CDMO communication to anticipate regulatory changes, assess manufacturing capabilities and secure the capital investment needed to maintain compliance
- Align EHS, sustainability and operations teams across the supply chain to eliminate conflicting priorities, coordinate environmental improvements and meet shared compliance and ESG targets
4:00 pm Chair’s Closing Remarks & End of Conference
4:15 pm Roundtable Discussion: Navigating PFAS, RCRA & Emerging Environmental Regulations to Mitigate Compliance Risks & Future-Proof Biopharma Operations
- Explore regulatory hot topics including PFAS restrictions, RCRA waste management requirements, and emerging environmental regulations affecting biopharma
- Learn strategies for proactive compliance monitoring and preparing your organization for regulatory changes before they become mandatory
- Gain insights into environmental aspects of laboratory operations and how to integrate environmental considerations into R&D and manufacturing processes